Clinical performance of the Elecsys® anti-SARS-CoV-2 combined in an algorithm with two specific anti-IgG immunoassays for the evaluation of the serological response of patients with COVID-19 in a population with a high prevalence of infection.
Xavier GabaldóSimona IftimieAnna Hernández-AguileraIsabel PujolFrederic BallesterLuis FernándezSara CladellasAntoni CastroJorge JovenJordi CampsJosep M SimóPublished in: Annals of clinical biochemistry (2021)
This study highlights the proper functioning of algorithms in the diagnosis of the immune response to COVID-19, which can help to define testing strategies against this disease.